Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Fid"

967 News Found

KPMG report finds healthcare CEOs betting big on AI amid workforce and system pressures
Healthcare | May 05, 2026

KPMG report finds healthcare CEOs betting big on AI amid workforce and system pressures

Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness


Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025
Biopharma | May 05, 2026

Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025

The private funding rose 38% amid growing international collaborations and CDMO demand


Redcliffe Labs elevates Gaurav Jain as Chief Operating Officer
People | May 05, 2026

Redcliffe Labs elevates Gaurav Jain as Chief Operating Officer

Leadership transition strengthens Redcliffe Labs’ focus on scaling technology-led diagnostics, operational excellence, and preventive healthcare access


SK Capital sells Noramco assets to Siegfried
News | May 05, 2026

SK Capital sells Noramco assets to Siegfried

Keeps Halo Pharma to drive independent growth


Karunanithi Ponnusamy elevated to President – Animal Health Business at Alembic Pharma
People | May 04, 2026

Karunanithi Ponnusamy elevated to President – Animal Health Business at Alembic Pharma

With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives


FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote
News | May 04, 2026

FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote

The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer


FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer
News | May 04, 2026

FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor


FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
News | May 02, 2026

FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win

The renewal covers two versions of the IQOS device and three HEETS tobacco variants


Thermo Fisher to sell microbiology business in $1.075 billion deal with Astorg
News | May 02, 2026

Thermo Fisher to sell microbiology business in $1.075 billion deal with Astorg

The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment


Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India
News | May 02, 2026

Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India

The transaction marks a clear portfolio reshuffle for Indoco